Life Science Compliance Update



A Last Hurrah as CDRH Issues Guidances Before Obama’s Departure

Written by , Posted in FDA

Kaitlin Fallon Wildoner, Esq., Senior Staff Writer, Life Science Compliance Update

In a last-minute attempt to put a permanent mark on the life sciences (and specifically, the medical device) industry, the outgoing Obama Administration issued a litany of final and draft guidances in a roughly six-week period. This article briefly reviews these new guidance documents.


Topic tags:

Menu Title